Cargando…

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease

Objective. Kawasaki disease (KD) is an acute systematic vasculitis in children which causes coronary arterial lesions and hydrops of gallbladder. Our objective is to correlate the clinical significance and influence on disease outcome of patients with gallbladder abnormalities in Kawasaki dissease....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chih-Jen, Huang, Fu-Chen, Tiao, Mao-Meng, Huang, Ying-Hsien, Lin, Li-Yan, Yu, Hong-Ren, Yang, Kuender D., Huang, Yi-Chuan, Chen, Chih-Cheng, Chang, Wei-Chiao, Kuo, Ho-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385618/ https://www.ncbi.nlm.nih.gov/pubmed/22792043 http://dx.doi.org/10.1100/2012/485758

Ejemplares similares

Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment
por: Lin, Li-Yan, et al.
Publicado: (2012)

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
por: Ou-Yang, Mei-Chen, et al.
Publicado: (2013)

Plasma Prostaglandin E(2) Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2016)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017)

Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study
por: Kuo, Ho-Chang, et al.
Publicado: (2013)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
por: Huang, Ying-Hua, et al.
Publicado: (2021)

Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis
por: Chiang, Wan-Ni, et al.
Publicado: (2023)

CD40 Gene Polymorphisms Associated with Susceptibility and Coronary Artery Lesions of Kawasaki Disease in the Taiwanese Population
por: Kuo, Ho-Chang, et al.
Publicado: (2012)

Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease
por: He, Lan, et al.
Publicado: (2021)

Comparative effectiveness of two intravenous immunoglobulin products in children with Kawasaki disease, a nationwide cohort study
por: Kuo, Ni-Chun, et al.
Publicado: (2023)

Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease
por: Huang, Ying-Hsien, et al.
Publicado: (2017)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Lack of Association between CLEC5A Gene Single-Nucleotide Polymorphisms and Kawasaki Disease in Taiwanese Children
por: Yang, Ya-Ling, et al.
Publicado: (2012)

Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
por: Ko, Tai-Ming, et al.
Publicado: (2018)

Significantly Lower Immunoglobulin M Levels 6 Months After Disease Onset in Patients With Kawasaki Disease With Coronary Artery Lesions
por: Chang, Ling‐Sai, et al.
Publicado: (2021)

DC-SIGN (CD209) Promoter −336 A/G (rs4804803) Polymorphism Associated with Susceptibility of Kawasaki Disease
por: Yu, Hong-Ren, et al.
Publicado: (2012)

Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study
por: Lin, Ming-Chih, et al.
Publicado: (2013)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease
por: Huang, Ying-Hsien, et al.
Publicado: (2016)

The human blood DNA methylome identifies crucial role of β-catenin in the pathogenesis of Kawasaki disease
por: Chen, Kuang-Den, et al.
Publicado: (2018)

Genetic Variants of CD209 Associated with Kawasaki Disease Susceptibility
por: Kuo, Ho-Chang, et al.
Publicado: (2014)

Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study
por: Liu, Jie, et al.
Publicado: (2022)

ITPKC Single Nucleotide Polymorphism Associated with the Kawasaki Disease in a Taiwanese Population
por: Kuo, Ho-Chang, et al.
Publicado: (2011)

Single-Nucleotide Polymorphism rs7251246 in ITPKC Is Associated with Susceptibility and Coronary Artery Lesions in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2014)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Multisource feedback analysis of pediatric outpatient teaching
por: Tiao, Mao-Meng, et al.
Publicado: (2013)

Use of Machine Learning to Differentiate Children With Kawasaki Disease From Other Febrile Children in a Pediatric Emergency Department
por: Tsai, Chih-Min, et al.
Publicado: (2023)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis
por: Huang, Yao-Hsien, et al.
Publicado: (2015)

Identifying Downregulation of Autophagy Markers in Kawasaki Disease
por: Huang, Fu-Chen, et al.
Publicado: (2020)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Augmented TLR2 Expression on Monocytes in both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis
por: Lin, I-Chun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0449afo6lcfv60f3jb29rendkf